Chr Hansen main owner completes sale to Novo fund
COPENHAGEN, March 29
COPENHAGEN, March 29 (Reuters) - The biggest shareholder in Danish food ingredients maker Chr. Hansen has sold a 25.7 percent stake to Novo A/S, cutting its holdings to 0.09 percent in line with a January announcement, Chr. Hansen said on Thursday.
Financiere Star 1 S.A., a fund controlled by private equity investment firm PAI Partners, sold about 35.42 million shares in Chr. Hansen Holding A/S to Novo A/S, Chr. Hansen said.
The companies had announced the deal on Jan. 11. .
Novo A/S is a foundation-owned company and the main shareholder in Danish drugmaker Novo Nordisk A/S and industrial enzymes maker Novozymes A/S.
Novo A/S said in January it aimed to be a long-term minority shareholder in Chr. Hansen and had no intention to take control of the company. (Reporting by John Acher, editing by Kristian Balsgaard Mortensen)
- Alabama man gets $1,000 in police settlement, his lawyers get $459,000
- Two killed, four wounded in Washington state school shooting
- Two U.S. states to quarantine health workers returning from Ebola zones |
- NYC police say hatchet attack by Islam convert was terrorism |
- 'We won't pay,' furious Cameron tells EU over surprise bill |